China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter,phase Ⅲ,randomized open-label clinical study of BL-B01D1 versus chemotherapy physician-selected in recurrent/ metastatic nasopharyngeal carcinoma patients treated with PD-1/L1 monoclonal'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134160
Registration Time: 2026/10/11
Type: Interventional study
Primary Sponsor: Sun Yat-sen University Cancer Center
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=216775
Published by HT Digital Content Services with permission from Health Daily Digest....